SCHEDULE 13G/A
Statement of Beneficial Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000921895-26-003175
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BVF PARTNERS L P/IL | 8,655,393 | 9.99% |
| BVF INC/IL | 8,655,393 | 9.99% |
| LAMPERT MARK N | 8,655,393 | 9.99% |
| BVF GP HOLDINGS LLC | 8,235,295 | 9.5% |
| BIOTECHNOLOGY VALUE FUND L P | 6,061,390 | 7.0% |
| BVF I GP LLC | 6,061,390 | 7.0% |
| BIOTECHNOLOGY VALUE FUND II LP | 2,173,905 | 2.6% |
| BVF II GP LLC | 2,173,905 | 2.6% |
| Biotechnology Value Trading Fund OS LP | 377,015 | 0.4% |
| BVF Partners OS Ltd. | 377,015 | 0.4% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…